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一THE STATISTIC OBSERVATION AND THE
 THERAPEUTIC EFFECT OF la－OH－D3一
Takuo KoiDE， Masato TAKEMoTo， Hiroaki IT・ATANi，
   Katsuhiro KiNosHiTA and Takao SoNoDA
Front theエ）ePartment cf Urolog．v， Osaka Universめ， School qプfi4edicine
       r．Z）irecgOr’Prげl T． SonOda，ルf， D．ノ
  Postoperative hypocalcemia in primary hyperparathyreidism， an unavoidable complication，
was studied statistically． Twe types were recognized in the pa ttern of the postoperative hypocalcemia．
One was that the recovery of serum calcium level was observed in the early period， 5th to 7th day
p．ostopera．tively and tvhe other was the prolonged severe hypocalcem．ia lasting more than 2 weeks pest－
operatively． Then， 1 a－OH－D3， which is expected to be converted to active form of vitamin D3， 1， 25一
（OH）2－D3， by 25－hydroxylation in the liver， was used for the treatment of the six hypocalcemic patients
belonging to the latter type． ln the results， la－OH－D3 was safe and effective so far as being controled
by serum calcium and urinary calcium excretion． We emphasize that the excessive excision ef the
parathyroid glands shpuld be avoided because the long－term management of the postoperative hypo－


















































































Fig． 1． serum Ca ievel of 5－7 days after operation
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Fig．2． A・B両グループの術後血清カルシウム値の推静
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Fig．3．術前の血清カルシウム値とA・B両グルー
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Case Age Sex Uroiithiasis Bone demineralization Histology
1 47 F． （＋）
2 43 F， （一｝
3 65 F． t十｝
4 37 M． t十）
5 32 M． （十1
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